[Increase in Parkinson symptoms caused by calcium antagonists].
Hefner
R
R
Abteilung für Neurologie, Universitätskliniken Frankfurt/M.
Fischer
P A
PA
D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005444:Flunarizine / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*
D002121:Calcium Channel Blockers; D005444:Flunarizine
Zunahme der Parkinson-Symptomatik unter Kalzium-Antagonisten.